Campanhã, Daniel; Lima, Eduardo Nóbrega Pereira; Alves, Fábio Abreu 
; Jaguar, Graziella Chagas
Source: Journal of Stomatology, Oral and Maxillofacial Surgery. Unidade: FO
Subjects: XEROSTOMIA, SIALADENITE, IODO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPANHÃ, Daniel et al. Bethanechol used to prevent salivary gland dysfunction in patients submitted to radioactive iodine therapy: a double blind, placebo controlled, randomized study. Journal of Stomatology, Oral and Maxillofacial Surgery, v. 122, n. 6, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jormas.2021.12.014. Acesso em: 09 set. 2024.APA
Campanhã, D., Lima, E. N. P., Alves, F. A., & Jaguar, G. C. (2021). Bethanechol used to prevent salivary gland dysfunction in patients submitted to radioactive iodine therapy: a double blind, placebo controlled, randomized study. Journal of Stomatology, Oral and Maxillofacial Surgery, 122( 6). doi:10.1016/j.jormas.2021.12.014NLM
Campanhã D, Lima ENP, Alves FA, Jaguar GC. Bethanechol used to prevent salivary gland dysfunction in patients submitted to radioactive iodine therapy: a double blind, placebo controlled, randomized study [Internet]. Journal of Stomatology, Oral and Maxillofacial Surgery. 2021 ;122( 6):[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.jormas.2021.12.014Vancouver
Campanhã D, Lima ENP, Alves FA, Jaguar GC. Bethanechol used to prevent salivary gland dysfunction in patients submitted to radioactive iodine therapy: a double blind, placebo controlled, randomized study [Internet]. Journal of Stomatology, Oral and Maxillofacial Surgery. 2021 ;122( 6):[citado 2024 set. 09 ] Available from: https://doi.org/10.1016/j.jormas.2021.12.014
